Novo Integrated Sciences, Inc., headquartered in Bellevue, Washington, filed a Form S-8 registration statement with the Securities and Exchange Commission (SEC) on September 23, 2024. The filing pertains to the company's 2023 Equity Incentive Plan, which is designed to offer equity-based incentives to employees. The company, incorporated in Nevada and led by CEO Robert Mattacchione, has included in the registration statement documents previously filed with the SEC, such as annual and quarterly reports, as well as descriptions of the company's capital stock. Novo Integrated Sciences is classified as a non-accelerated filer and a smaller reporting company, indicating it does not meet the criteria for larger public companies in terms of market capitalization and reporting requirements. The company's transfer agent is Pacific Stock Transfer Company, located in Las Vegas, Nevada.

Novo Integrated Sciences, Inc., headquartered in Bellevue, Washington, filed a Form S-8 registration statement with the Securities and Exchange Commission (SEC) on September 23, 2024. The filing pertains to the company's 2023 Equity Incentive Plan, which is designed to offer equity-based incentives to employees. The company, incorporated in Nevada and led by CEO Robert Mattacchione, has included in the registration statement documents previously filed with the SEC, such as annual and quarterly reports, as well as descriptions of the company's capital stock. Novo Integrated Sciences is classified as a non-accelerated filer and a smaller reporting company, indicating it does not meet the criteria for larger public companies in terms of market capitalization and reporting requirements. The company's transfer agent is Pacific Stock Transfer Company, located in Las Vegas, Nevada.